Dynamic Changes of Serum Heart Type-Fatty Acid Binding Protein in Cancer Patients Treated With Immune Checkpoint Inhibitors

Dynamic Changes of Serum Heart Type-Fatty Acid Binding Protein in Cancer Patients Treated With Immune Checkpoint Inhibitors

Objective: Immune checkpoint inhibitors (ICIs) are effective anti-cancer drugs that can improve survival in cancer patients, but their use may be associated with adverse cardiovascular side effects. Therefore, there is a clinical unmet need to identify non-invasive biomarker to detect subclinical ca...

Full description

Bibliographic Details
Main Authors: Ming Yuan, Li Zang, Aiqing Xu, Mengqi Gong, Qing Liu, Bin Huo, Jinhuan Wang, Huaying Fu, Gary Tse, Leonardo Roever, Guangping Li, Haitao Wang, Tong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
cardio-oncology
cardiotoxicity
immune checkpoint inhibitors
H-FABP
immune-related adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.748677/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.748677/full

Similar Items